Page last updated: 2024-10-26

etodolac and Infections, Helicobacter

etodolac has been researched along with Infections, Helicobacter in 4 studies

Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.

Research Excerpts

ExcerptRelevanceReference
"Some adaptation occurred in over 90% of subjects after 4 weeks dosing with an NSAID, but adaptation was less frequent in older subjects and in smokers."1.30The influence of age, gender, Helicobacter pylori and smoking on gastric mucosal adaptation to non-steroidal anti-inflammatory drugs. ( Campbell, F; Lipscomb, GR; Rees, WD, 1997)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Magari, H1
Shimizu, Y1
Inada, K1
Enomoto, S1
Tomeki, T1
Yanaoka, K1
Tamai, H1
Arii, K1
Nakata, H1
Oka, M1
Utsunomiya, H1
Tsutsumi, Y1
Tsukamoto, T1
Tatematsu, M1
Ichinose, M1
Laine, L1
Cominelli, F1
Sloane, R1
Casini-Raggi, V1
Marin-Sorensen, M1
Weinstein, WM1
Lipscomb, GR1
Campbell, F1
Rees, WD1
Xiao, F1
Furuta, T1
Takashima, M1
Shirai, N1
Hanai, H1

Trials

1 trial available for etodolac and Infections, Helicobacter

ArticleYear
Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double-blind trial.
    Alimentary pharmacology & therapeutics, 1995, Volume: 9, Issue:2

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Etodolac; Gas

1995

Other Studies

3 other studies available for etodolac and Infections, Helicobacter

ArticleYear
Inhibitory effect of etodolac, a selective cyclooxygenase-2 inhibitor, on stomach carcinogenesis in Helicobacter pylori-infected Mongolian gerbils.
    Biochemical and biophysical research communications, 2005, Aug-26, Volume: 334, Issue:2

    Topics: Animals; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Etodolac; Gerbillinae; Helicob

2005
The influence of age, gender, Helicobacter pylori and smoking on gastric mucosal adaptation to non-steroidal anti-inflammatory drugs.
    Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:5

    Topics: Adolescent; Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Tole

1997
Effects of cyclooxygenase-2 inhibitor on gastric acid secretion in Helicobacter pylori-infected C57BL/6 mice.
    Scandinavian journal of gastroenterology, 2001, Volume: 36, Issue:6

    Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Eto

2001